Contat
We are always open to discussions regarding scientific collaborations, strategic partnerships and investment inquiries.
Address
426, rue des Divaises 14160 Dives-sur-Mer (France)
anne.michel@hermionetherapeutics.com
Why Support Hermione Therapeutics?
Best-in-Class Platform
Targeting bacterial biofilms rather than bacteria directly. Broad potential to treat multiple pathogens’ biofilm-associated indications.
High Unmet Medical Need
Focused on COPD and bronchiectasis associated with P. aeruginosa.
Robust Scientific Evidence
Supported by peer-reviewed publications, a documented MoA and robust preclinical evidence.
Validated Proof of Concept
Demonstrated biofilm dispersion and enhanced antibiotic activity in both in vitro and in vivo studies.
Protected Innovation
Patent portfolio, freedom-to-operate assessment and ongoing intellectual property strategy.
Public Health Impact
Reducing bacterial persistence and supporting more responsible antibiotic use in the fight against antimicrobial resistance.
Interested in Our Technology?
Learn how ANP is designed to disperse bacterial biofilms and restore antibiotic efficacy.
